Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow Quality Index

Latest as of June 2023: -5.35x

Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Quality Index of -5.35x as of June 2023. Operating cash flow of CN¥-455.48 Million is below net income of CN¥85.14 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 688298 total asset value for the complete picture of this company's asset base.

Cash Flow Quality Index

-5.35x
Operating CF / Net Income

Operating Cash Flow

CN¥-455.48 Million
CNY

Net Income

CN¥85.14 Million
CNY

Data as of

Jun 2023
Most recent filing

Zhejiang Orient Gene Biotech Co Ltd Cash Flow Quality Index (2016–2022)

Historical Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Orient Gene Biotech Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)

Year-by-year earnings quality comparison for Zhejiang Orient Gene Biotech Co Ltd. For live market cap and the full company financial profile, see market value of Zhejiang Orient Gene Biotech Co Ltd.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2022 1.43x CN¥3.00 Billion CN¥2.10 Billion ▲ +35.6%
2021 1.05x CN¥5.20 Billion CN¥4.94 Billion ▼ -1.1%
2020 1.07x CN¥1.79 Billion CN¥1.68 Billion ▲ +52.3%
2019 0.70x CN¥54.21 Million CN¥77.51 Million ▲ +0.9%
2018 0.69x CN¥44.33 Million CN¥63.96 Million ▼ -32.4%
2017 1.03x CN¥33.54 Million CN¥32.71 Million ▲ +209.4%
2016 0.33x CN¥11.81 Million CN¥35.63 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.